Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135089) titled 'Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: General Hospital of Shenyang Military Region
Condition:
Stroke, Ischemic
Intervention:
Drug: Intravenous tirofiban before endovascular thrombectomy
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 1, 2025
Target Sampl...